Trials / Completed
CompletedNCT01245465
Profermin® in Active Ulcerative Colitis
Safety and Efficacy of Profermin® to Induce Remission in Patients With Ulcerative Colitis
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Nordisk Rebalance A/S · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
In this study the investigators aim was to investigate the safety and possible efficacy of Profermin® in patients with ulcerative colitis. The investigators also aimed at assessing the usefulness of a new online daily symptom registration system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Profermin | Medical Food (food for special medical purposes) |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-11-01
- Completion
- 2009-11-01
- First posted
- 2010-11-22
- Last updated
- 2010-11-23
Source: ClinicalTrials.gov record NCT01245465. Inclusion in this directory is not an endorsement.